期刊文献+

可塑形脱矿骨基质/透明质酸骨泥的制备与细胞相容性 被引量:2

Preparation and cell compatibility of malleable demineralized bone matrix/hyaluronic acid putty
下载PDF
导出
摘要 背景:应用预制成形的材料修复不规则骨缺损时,常出现材料与骨缺损形状不匹配的问题,制备可任意塑形骨泥对促进不规则骨缺损的愈合具有重要意义。目的:构建可塑形脱钙骨基质/透明质酸骨泥,筛选最佳复合比例并评价其细胞相容性。方法:选取合格供体皮质骨制备脱钙骨基质。分别配置浓度为0.75%,1.5%,3%,4.5%的透明质酸溶液并检测其黏度,以450 mg脱钙骨基质与上述各浓度透明质酸溶液1 mL混合,制备不同比例的脱钙骨基质/透明质酸骨泥。37℃条件下将骨泥浸泡在PBS平衡液中,观察其离散时间,筛选最佳复合比例的脱钙骨基质/透明质酸骨泥。应用脱钙骨基质/透明质酸骨泥浸提液培养L-929小鼠成纤维细胞,1,4,7 d采用CCK-8法检测骨泥的细胞毒性。结果与结论:随透明质酸浓度的增加其溶液黏度增大,脱钙骨基质/透明质酸骨泥的离散时间延长,3%浓度的透明质酸与450 mg脱钙骨基质复合制备的骨泥具有良好可塑形能力,离散时间为8 h,为最佳复合比例。脱钙骨基质/透明质酸骨泥浸提液培养L-929小鼠成纤维细胞1,4,7 d的细胞增殖率分别为93.72%,101.65%,97.68%,细胞毒性级别为0或1级。表明脱钙骨基质/透明质酸复合质量比为15∶1制备的骨泥具有良好的可塑形能力及抗离散能力,细胞毒性轻微。 BACKGROUND: It is important to prepare a malleable putty to repair irregular bone defects because the preformed bone substitute material cannot suit to bone defects.OBJECTIVE: To prepare malleable demineralized bone matrix/hyaluronic acid putty and to screen out the optimal composite ratio, as well as to evaluate its cell compatibility.METHODS: Demineralized bone matrix was prepared from the cortical bone of healthy donors. The hyaluronic acid was dissolved at concentrations of 0.75%, 1.5%, 3%, 4.5%, and the viscosity of them was measured. Then 450 mg demineralized bone matrix was compounded with 1 mL hyaluronic acid solution to prepare the demineralized bone matrix/hyaluronic acid putty, and the optimal ratio of demineralized bone matrix/hyaluronic acid was screened by the disintegrated time of the putty at 37 ℃. L-929 mouse fibroblasts were cultured in the leaching liquor of demineralizedbone matrix/hyaluronic acid, and the cytotoxicity was tested by cell count kit-8 assay at days 1, 4 and 7.RESULTS AND CONCLUSION: With the increase of hyaluronic acid concentration, the viscosity of hyaluronic acid solution was increased; the demineralized bone matrix/hyaluronic acid putty was strengthened and the disintegrated time was prolonged gradually. When the ratio of demineralized bone matrix/hyaluronic acid was 15/1, demineralized bone matrix/hyaluronic acid was molded easily, and the disintegrated time was 8 hours in 7 ℃ PBS. The results of cytotoxicity showed that cell proliferation rates were 93.72%, 101.65% and 97.68% at days 1, 4 and 7 respectively, while the cytotoxicity was in grade 0 or 1. These findings indicate that demineralized bone matrix/hyaluronic acid putty at a compound ratio of 15:1 can be molded easily and difficult to disintegrate, with low cytotoxicity.
出处 《中国组织工程研究》 CAS CSCD 2013年第47期8182-8188,共7页 Chinese Journal of Tissue Engineering Research
基金 中国辐射防护研究院青年科技基金资助项目(YQ120807)~~
  • 相关文献

参考文献19

  • 1张乃丽,李宝兴,张育敏,周沫.可塑形骨泥的研究进展[J].中国修复重建外科杂志,2012,26(11):1391-1397. 被引量:2
  • 2Kobayashi H,Sun GW,Terao T. Production of prostanoids via increased cyclo-oxygenase-2 expression in human amnion cells in response to low molecular weight hyaluronic acid fragment[J].Biochimica Et Biophysica Acta,1998,(02):369-376.
  • 3Chung C,Beecham M,Mauck RL. The influence of degradation characteristics of hyaluronic acid hydrogels on in vitro neocartilage formation by mesenchymal stem cells[J].Biomaterials,2009,(26):4287-4296.doi:10.1016/j.biomaterials.2009.04.040.
  • 4Darby I. Periodontal materials[J].Australian Dental Journal,2011.107-118.
  • 5Dereure O. Hyaluronic acid and immunity[J].Annales de Dermatologie et de Vénéréologie,2010,(Suppl 1):S26-S29.
  • 6Ibrahim S,Kang QK,Ramamurthi A. The impact of hyaluronic acid oligomer content on physical,mechanical,and biologic properties of divinyl sulfone-crosslinked hyaluronic acid hydrogels[J].Journal of Biomedical Materials Research Part A,2010,(02):355-370.
  • 7Jae KK,Periasamy S,Jae HK. Structural and antioxidant properties of gamma irradiated hyaluronic acid[J].Food Chemistry,2008,(04):763-770.doi:10.1016/j.foodchem.2008.01.038.
  • 8Termeer C,Benedix F,Sleeman J. Oligosaccharides of Hyaluronan activate dendritic cells via tol-like receptor 4[J].Journal of Experimental Medicine,2002,(01):99-111.
  • 9孙晓雷,马信龙,马剑雄,张弢,王志刚,王涛,张华锋.牛脱细胞骨基质的生物力学特性及其黏附性[J].中国组织工程研究与临床康复,2008,12(49):9659-9663. 被引量:5
  • 10Day AJ,de la Motte CA. Hyaluronan cross-linking:a protective mechanism in inflammation[J].Trends in Immunology,2005,(12):637-643.doi:10.1016/j.it.2005.09.009.

二级参考文献63

  • 1孙新君,王正国,朱佩芳,周萍,张宇,刘大维,张猛.脱细胞异种骨基质植入后受体外周血T淋巴细胞亚型的变化[J].中国修复重建外科杂志,2005,19(4):322-325. 被引量:13
  • 2崔福斋,廖素三,关凯,孙天胜.矿化胶原基骨材料与BMP-2复合用于兔腰椎横突间融合[J].生物骨科材料与临床研究,2003,1(1):1-5. 被引量:38
  • 3孙新君,王正国,朱佩芳,张猛,张宇,周继红.脱细胞骨基质材料的特性及生物安全性观察[J].中华创伤杂志,2005,21(11):833-837. 被引量:16
  • 4Durham SR, McComb JG, Levy ML. Correction of large (>25 cm(2)) cranial defects with "reinforced" hydroxyapatite cement: technique and complications. Neurosurgery, 2003, 52 (4): 842-845.
  • 5Baroth S, Bourges X, Goyenvalle E, et al. Injectable biphasic calcium phosphate bioceramic: The HYDROS concept. Biomed Mater Eng, 2009, 19(1): 71-76.
  • 6Babbush CA. Histologic evaluation of human biopsies after dental augmentation with a demineralized bone matrix putty. Implant Dent, 2003, 12(4): 325-332.
  • 7Yee AJ, Bae HW, Friess D, et al. Augmentation of rabbit posterolateral spondylodesis using a novel demineralized bone matrix-hyaluronan putty. Spine (Phila Pa 1976), 2003, 28(21): 2435-2440.
  • 8Pietrzak WS, Perns SV, Keyes J, et al. Demineralized bone matrix graft: a scientific and clinical case study assessment. J Foot Ankle Surg, 2005, 44(5): 345-353.
  • 9Wildemann B, Kadow-Romacker A, Haas NP, et al. Quantification of various growth factors in different demineralized bone matrix preparations. J Biomed Mater Res A, 2007, 81(2): 437-442.
  • 10Bae H, Zhao L, Zhu D, et al. Variability across ten production lots of a single demineralized bone matrix product. J Bone Joint Surg (Am), 2010, 92(2): 427-435.

共引文献7

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部